Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday ...

Bright Minds Biosciences (TSE:DRUG) has released an update. Bright Minds Biosciences is teaming up again with Firefly Neuroscience to analyze ...

Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial evaluating ...

Bright Minds Biosciences (DRUG) announced that it is once again collaborating with Firefly Neuroscience (AIFF), an Artificial Intelligence ...

Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI ...

Its leading candidate, BMB-101, targets serotonin receptors (5-HT2C) to influence brain functions, with promising potential in epilepsy. Bright Minds is also working on BMB-202 to address ...

Alpha Cognition Inc. ("Alpha Cognition" or the "Company"), a biopharmaceutical company committed to developing novel ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

BMB-201, a selective 5-HT2A/2C receptor agonist, was designed to harness the analgesic potential of serotonin modulation ...

Bright Minds Biosciences (NASDAQ: DRUG), a little-known biotech company, became the talk of the market yesterday after its ...

The headset recorded brain activity at four different timepoints around the administration of BMB-101. Jon Olsen, CEO of Firefly, expressed optimism about the AI platform's role in advancing ...

The headset recorded brain activity at four different timepoints around the administration of BMB-101. Jon Olsen, CEO of Firefly, expressed optimism about the AI platform's role in advancing clinical ...